RecruitingNCT06160921

Prognostic Model of Hypertension


Sponsor

Xinjiang Medical University

Enrollment

50,000 participants

Start Date

Jan 1, 2020

Study Type

OBSERVATIONAL

Conditions

Summary

The aim of this study was to establish a registration and monitoring system for hypertension in Xinjiang from 2020 to 2030 to obtain real information about patient basic information, patient characteristics, diagnostic test patterns, treatment options, and hospitalization outcomes (including mortality). Treatment complications, hospitalization costs, and end-of-life events (death, major adverse cardiac events, mild adverse cardiovascular events) in patients with hypertension in Xinjiang; and scientific prevention strategies aimed at effectively preventing the onset of hypertension; Guidelines in clinical practice recommend, analyze and develop effective treatment strategies to optimize management and outcomes for patients with hypertension; and create cost-effective assessment systems.


Eligibility

Inclusion Criteria1

  • A patient diagnosed with primary hypertension who was admitted to the First Affiliated Hospital of Xinjiang Medical University

Exclusion Criteria2

  • Patients with secondary hypertension, patients with liver and kidney dysfunction,
  • patients with mental disorders, and patients who are unwilling to participate in this trial

Interventions

OTHERStandard therapy

Individualized blood pressure reduction program


Locations(1)

The First Affiliated Hospital of Xinjiang Medicial University

Ürümqi, Xinjiang, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06160921


Related Trials